相似文献
1
Weak D and partial D: our experience in daily activity.
Blood Transfus. 2012 Apr;10(2):235-6. doi: 10.2450/2012.0060-11. Epub 2012 Feb 13.
2
Rh haemolytic disease of the newborn and Rh genotyping by RFLP--and allele-specific--PCR.
Transfus Clin Biol. 1995;2(4):317-24. doi: 10.1016/s1246-7820(05)80098-9.
3
Review: the Rh blood group D antigen... dominant, diverse, and difficult.
Immunohematology. 2005;21(4):155-63.
4
Weak D type 1.1 exemplifies another complexity in weak D genotyping.
Transfusion. 2005 Oct;45(10):1568-73. doi: 10.1111/j.1537-2995.2005.00585.x.
5
RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22221. Epub 2017 Apr 4.
6
[Contribution of red blood group genotyping for recipients in immune-hematology through three years of activity at the EFS Alpes-Méditerranée].
Transfus Clin Biol. 2014 Dec;21(6):289-95. doi: 10.1016/j.tracli.2014.06.001. Epub 2014 Oct 16.
7
Molecular characterization of three novel weak D type alleles with additional haplotype data on weak D Types 1.2 and 18.
Transfusion. 2017 Apr;57(4):1092-1093. doi: 10.1111/trf.14045. Epub 2017 Feb 24.
8
Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.
Transfusion. 2011 Feb;51(2):401-11. doi: 10.1111/j.1537-2995.2010.02830.x. Epub 2010 Aug 16.
9
Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
Vox Sang. 2005 Feb;88(2):130-5. doi: 10.1111/j.1423-0410.2005.00604.x.
10
Weak D phenotypes and transfusion safety: where do we stand in daily practice?
Transfusion. 2007 Sep;47(9):1616-20. doi: 10.1111/j.1537-2995.2007.01332.x.
引用本文的文献
1
Testing for weak D Antigen: Spectrum and its applied role in rhesus-negative transfusions in Andaman and Nicobar Islands.
Tzu Chi Med J. 2019 Apr 2;32(2):167-170. doi: 10.4103/tcmj.tcmj_222_18. eCollection 2020 Apr-Jun.
2
A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.
Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3.
3
Prevalence of RhD variants among blood donors at Gulu Regional Blood Bank, Gulu, Northern Uganda.
J Blood Med. 2017 Sep 15;8:151-154. doi: 10.2147/JBM.S145550. eCollection 2017.
4
Enigmatic Weak D antigen: An Experience in a Tertiary Care Hospital of East Delhi.
J Clin Diagn Res. 2016 Jun;10(6):EC12-5. doi: 10.7860/JCDR/2016/16278.7972. Epub 2016 Jun 1.
5
Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
BMC Res Notes. 2016 Apr 1;9:198. doi: 10.1186/s13104-016-2002-x.
6
Rh D blood group conversion using transcription activator-like effector nucleases.
Nat Commun. 2015 Jun 16;6:7451. doi: 10.1038/ncomms8451.
本文引用的文献
1
Molecular genetics and clinical applications for RH.
Transfus Apher Sci. 2011 Feb;44(1):81-91. doi: 10.1016/j.transci.2010.12.013. Epub 2011 Jan 28.
2
The molecular genetics of blood group polymorphism.
Hum Genet. 2009 Dec;126(6):729-42. doi: 10.1007/s00439-009-0738-2. Epub 2009 Aug 29.
3
Blood group genotyping in Germany.
Transfusion. 2007 Jul;47(1 Suppl):47S-53S. doi: 10.1111/j.1537-2995.2007.01310.x.
4
Are weak D RBCs really immunogenic?
Transfusion. 2006 Jun;46(6):1061-2. doi: 10.1111/j.1537-2995.2006.00847.x.
Zotero 插件